ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 102 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $95,000 | -61.7% | 100,000 | -51.7% | 0.01% | -61.1% |
| Q2 2022 | $248,000 | +89.3% | 206,856 | +106.9% | 0.02% | +157.1% |
| Q1 2022 | $131,000 | -25.6% | 100,000 | 0.0% | 0.01% | +16.7% |
| Q4 2021 | $176,000 | -59.4% | 100,000 | -50.0% | 0.01% | -64.7% |
| Q3 2021 | $434,000 | -89.8% | 200,000 | -44.3% | 0.02% | -95.6% |
| Q2 2019 | $4,268,000 | +124.7% | 358,986 | -0.9% | 0.39% | +125.6% |
| Q1 2019 | $1,899,000 | +66.3% | 362,386 | 0.0% | 0.17% | +149.3% |
| Q4 2018 | $1,142,000 | +560.1% | 362,386 | +1169.6% | 0.07% | +527.3% |
| Q3 2018 | $173,000 | -91.0% | 28,544 | -94.8% | 0.01% | -93.2% |
| Q4 2017 | $1,925,000 | -4.1% | 550,000 | 0.0% | 0.16% | -23.2% |
| Q3 2017 | $2,008,000 | +88.9% | 550,000 | +29.4% | 0.21% | +34.4% |
| Q2 2017 | $1,063,000 | +12.5% | 425,000 | +21.4% | 0.16% | +6.8% |
| Q1 2017 | $945,000 | +30.3% | 350,000 | +40.0% | 0.15% | +182.7% |
| Q4 2016 | $725,000 | – | 250,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,112,355 | $40,178,000 | 34.81% |
| Versant Venture Management, LLC | 7,068,233 | $69,056,636,000 | 18.94% |
| ACUTA CAPITAL PARTNERS, LLC | 1,704,500 | $16,653,000 | 8.07% |
| Soleus Capital Management, L.P. | 313,900 | $3,067,000 | 3.57% |
| Ghost Tree Capital, LLC | 1,305,500 | $12,755,000 | 3.38% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $4,690,000 | 2.97% |
| RTW INVESTMENTS, LP | 6,631,627 | $64,791,000 | 2.79% |
| VR Adviser, LLC | 994,381 | $9,715,000 | 2.63% |
| Avoro Capital Advisors LLC | 7,150,000 | $69,856,000 | 2.36% |
| RA Capital Management | 7,272,714 | $71,054,000 | 2.24% |